Article
An update on the US adult thalassaemia population: a report from the CDC thalassaemia treatment centres.
British journal of haematology - 1 Jan 2022
Chapin John, Cohen Alan R, Neufeld Ellis J, Vichinsky Elliott, Giardina Patricia J, Boudreaux Jeanne, Le Binh C, Kenney Kristy, Trimble Sean, Thompson Alexis A
Abstract excerpt
Thalassaemia is caused by genetic globin defects leading to anaemia, transfusion-dependence and comorbidities. Reduced survival and systemic organ disease affect transfusion-dependent thalassaemia major and thalassaemia intermedia. Recent improvements in clinical management have reduced thalassaemia mortality. The therapeutic landscape of thalassaemia may soon include gene therapies as functional cures. An...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
